Skip to main content
Hearn Cho, MD, Hematology, New York, NY

HearnJayChoMD

Hematology • New York, NY

Assistant Professor, Medicine, Icahn School of Medicine at Mount Sinai

Request Appointment

Overview of Dr. Cho

Dr. Hearn Cho is a hematologist in New York, NY and is affiliated with The Mount Sinai Hospital. He received his medical degree from Weill Cornell Medicine and has been in practice 21 years. Dr. Cho accepts several types of health insurance, listed below. He is one of 52 doctors at The Mount Sinai Hospital who specialize in Hematology. He has more than 80 publications and over 500 citings.

Education & Training

  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Fellowship, Hematology and Medical Oncology, 2000 - 2002
  • University of California (San Diego) Medical Center
    University of California (San Diego) Medical CenterResidency, Internal Medicine, 1996 - 2000
  • Weill Cornell Medicine
    Weill Cornell MedicineClass of 1996

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1998 - Present
  • FL State Medical License
    FL State Medical License 2022 - Present
  • NY State Medical License
    NY State Medical License 2000 - 2025

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Outcomes in Multiple Myeloma Patients Progressing on Lenalidomide Maintenance
    Hearn Jay Cho, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • A Machine Learning Approach Identifies a 30-Gene Model That Predicts Sensitivity to Selinexor in Multiple Myeloma
    Hearn Jay Cho, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • ADAR1 Drives Disease Progression in Multiple Myeloma By Acting Both As an RNA Editor of Specific Transcripts and As a DNA Mutator of Their Cognate Genes
    Hearn Jay Cho, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Lectures

  • High Dimensional Immune Profiling in Smoldering Multiple Myeloma Identifies Novel Organizing Features of the Tumor Microenvironment 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Increased HLA-E Expression Correlates with Early Relapse in Multiple Myeloma 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Mechanisms of CD4 T Cell Tumor Immunity in a Preclinical Model of Multiple Myeloma 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

  • Researchers Find Link Between Genetic Mutations and Cancer Treatment Resistance
    Researchers Find Link Between Genetic Mutations and Cancer Treatment ResistanceJuly 26th, 2022
  • New Orleans Partnership Aims to Cure Cancer That Often Has Racial Disparity for Treatment
    New Orleans Partnership Aims to Cure Cancer That Often Has Racial Disparity for TreatmentMarch 18th, 2022
  • Multiple Myeloma Awareness Month: 2022 Immunotherapy Research Updates
    Multiple Myeloma Awareness Month: 2022 Immunotherapy Research UpdatesMarch 2nd, 2022
  • Join now to see all

Grant Support

  • Type 1 MAGE Vaccine Immunotherapy For Multiple MyelomaNational Cancer Institute2006–2010

Professional Memberships

Insurance Accepted

  • Aetna Choice POS II
    Aetna HMO
    BCBS Blue Card PPO
    BCBS Illinois PPO
    CIGNA HMO
    CIGNA Open Access
    CIGNA PPO
    Empire BCBS HMO
    Empire BCBS PPO
    First Health PPO
    GHI PPO
    Great West PPO
    HealthLink PPO
    HIP of New York - Select PPO
    Humana ChoiceCare Network PPO
    MagnaCare PPO
    Multiplan PHCS PPO
    Multiplan PPO
    Oxford Health Freedom
    Oxford Health Liberty
    United Healthcare - Direct Choice Plus POS
    United Healthcare - Direct Options PPO
  • Please verify your coverage with the provider's office directly when scheduling an appointment

Dr. Hearn Cho, Dr. Hearn Cho, MD, Dr. H Cho, Dr. Hearn Jay Cho